secwatch.observer — SEC 8-K summary
======================================

Issuer:     Opus Genetics, Inc. (IRD)
CIK:        0001228627
Form:       8-K
Filed at:   2025-04-04T23:59:59+00:00
Accession:  0001140361-25-012366
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Opus Genetics terminates $50M equity purchase agreement with Lincoln Park Capital
--------------------------------------------------------------------------------

- Terminated Purchase Agreement with Lincoln Park Capital effective April 3, 2025.
- Agreement allowed up to $50M in stock sales; company cites limited value given current market price.
- Prior to termination, issued 1.7M shares for net proceeds of ~$5.2M; remaining $44.8M facility cancelled.
- Registration obligations under the agreement survive termination for 90 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1228627/000114036125012366/0001140361-25-012366-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1228627/000114036125012366/ef20046946_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-012366

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer